Welcome to our dedicated page for Exponent SEC filings (Ticker: EXPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exponent Inc filings document operating results, Regulation FD disclosures, capital-return actions, and governance matters for a science and engineering consulting company. Recent Form 8-K reports record quarterly financial results, dividend declarations, and share repurchase authorizations tied to the company’s common stock.
Proxy materials cover shareholder voting matters, director elections, executive compensation, pay-versus-performance tables, and board governance. The filing record also includes material-event disclosures related to leadership and corporate governance, along with capital-structure disclosures relevant to Exponent’s public-company reporting.
Sala Joseph reported acquisition or exercise transactions in this Form 4 filing.
Exponent Inc reported that Group Vice President Joseph Sala received a grant of 9,798 Restricted Stock Units on March 13, 2026. These RSUs are a form of stock-based compensation, with each unit convertible into one share of Exponent common stock on a 1-for-1 basis.
Following this award, Sala holds 9,798 RSUs directly, all tied to Exponent common stock. The grant was made at no cash cost per unit and reflects routine executive equity compensation rather than an open-market stock purchase or sale.
Exponent Inc reported that Group Vice President Maureen T. F. Reitman received a grant of 9,500 restricted stock units (RSUs) on March 13, 2026. Each RSU represents a right to receive one share of Exponent common stock, giving her 9,500 RSUs outstanding after this award. These units vest into common shares based on the company’s terms, with an exercise and expiration date in March 2030, and were granted at no cash cost to her as part of equity compensation.
Reiss Richard reported acquisition or exercise transactions in this Form 4 filing.
Exponent Inc reported that Group Vice President Richard Reiss received a grant of 2,970 restricted stock units on March 13, 2026. These RSUs represent the right to receive 2,970 shares of common stock on a 1-for-1 basis, as noted in the footnotes. Following this award, his reported derivative holdings in these RSUs total 2,970 units, reflecting routine equity-based compensation rather than any open-market buying or selling of shares.
Exponent Inc reported that Group Vice President Joseph Rakow received a grant of 10,688 restricted stock units on March 13, 2026. These RSUs represent a right to receive an equal number of shares of Exponent common stock on a 1-for-1 basis and are shown at a price of $0.00 because they are an equity award, not a market purchase. Following this grant, Rakow holds 10,688 RSUs directly, with an exercise and expiration date of March 13, 2030.
Exponent Inc reported that VP Global Offices & Innovation John Pye received a grant of 5,938 restricted stock units (RSUs) on March 13, 2026. These RSUs are a compensation-related award with a stated price of $0.00 per unit and each unit is exchangeable on a 1-for-1 basis into shares of common stock.
Following this award, Pye holds 5,938 RSUs directly. The RSUs relate to an equal number of underlying shares of common stock and are scheduled with an exercise and expiration date of March 13, 2030, indicating a long-term equity incentive rather than an open-market purchase.
Kundert Brian reported acquisition or exercise transactions in this Form 4 filing.
Exponent Inc. reported that Chief Human Resources Officer Brian Kundert received a grant of 3,564 restricted stock units on March 13, 2026. These units represent a 1-for-1 right to receive shares of common stock, typically as part of long-term equity compensation.
Following this award, he is reported as holding 3,564 restricted stock units directly. The transaction is recorded as a grant or award, not an open-market purchase or sale, and therefore reflects standard executive compensation rather than a discretionary trade.
Exponent Inc reported that Group Vice President James Bradley A received a grant of 4,454 Restricted Stock Units (RSUs) on March 13, 2026. These RSUs represent rights to receive an equal number of shares of common stock on a 1-for-1 basis.
The grant is a compensation-related award at no purchase cost, rather than an open-market transaction. Following this award, Bradley holds 4,454 RSUs directly. The RSUs are scheduled with an exercise and expiration date of March 13, 2030, indicating the expected settlement period for the underlying common shares.
Exponent Inc. President and CEO Catherine Corrigan received a grant of 17,814 restricted stock units on March 13, 2026. These RSUs are a form of equity compensation and are directly owned. Each unit is exchangeable on a 1-for-1 basis into Exponent common stock. Following this award, Corrigan holds 17,814 RSUs tied to an equivalent number of underlying common shares, with a stated conversion and expiration date of March 13, 2030.
Exponent Inc Group Vice President Richard Reiss reported routine equity compensation activity. He exercised 2,120 Restricted Stock Units granted on March 11, 2022, converting them into an equal number of common shares on a 1:1 basis. To cover related tax obligations, the company withheld 958 common shares at a value of $70.03 per share. After these transactions, Reiss directly holds 3,960 shares of Exponent common stock, indicating a net increase in his ownership from this award vesting and tax withholding event.
Exponent Inc.’s EVP & Chief Financial Officer Richard L. Schlenker Jr. exercised vested equity awards and had shares withheld for taxes. He converted 7,630 Restricted Stock Units granted on March 11, 2022 into 7,630 shares of Common Stock on a 1:1 basis. To satisfy tax withholding obligations, 3,694 Common Stock shares were withheld by the company, leaving him with 230,351 Common Stock shares held directly after these transactions. These actions represent routine equity compensation vesting and related tax settlement rather than open-market buying or selling.